Wall Street analysts forecast that Tenet Healthcare (THC) will report quarterly earnings of $2.33 per share in its upcoming release, pointing to a year-over-year increase of 61.8%. It is anticipated that revenues will amount to $5.05 billion, exhibiting a decline of 0.4% compared to the year-ago quarter. Over the last 30 days, there has been an upward revision of 0.2% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration ...

Hospital company Tenet Healthcare Corporation (THC) is set to report its third-quarter 2024 results on Oct. 29, 2024, before the opening bell. The Zacks Consensus Estimate for the to-be-reported quarter’s earnings and revenues is pegged at $2.33 per share and $5.05 billion, respectively.Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.The earnings estimate for the to-be-reported quarter has remained stable over the past 60 days. The bottom-line projection indicates year-over-year gro ...

Hospital company Tenet Healthcare Corporation (THC) is trading comparatively cheap at the moment from a valuation standpoint. Its forward earnings multiple of 14.75 is lower than the industry average of 16.18. The stock also looks attractively valued relative to other medical facility operators like HCA Healthcare, Inc. (HCA) and Encompass Health Corporation (EHC) , with forward 12-month P/E of 16.62X and 21.33X. Tenet Healthcare has a Value Score of A. Zacks Investment Research Image Source: Zacks Investme ...

Tenet Healthcare (THC) closed the most recent trading day at $152.78, moving -0.84% from the previous trading session. The stock's performance was behind the S&P 500's daily loss of 0.21%. Elsewhere, the Dow saw a downswing of 0.14%, while the tech-heavy Nasdaq depreciated by 0.05%. Prior to today's trading, shares of the hospital operator had lost 2.28% over the past month. This has was narrower than the Medical sector's loss of 3.28% and lagged the S&P 500's gain of 5.94% in that time. The investment comm ...

Group 1 - Tenet Healthcare's stock closed at $156.57, reflecting a slight decrease of -0.11% from the previous session, underperforming compared to the S&P 500's gain of 0.9% [1] - Over the past month, Tenet Healthcare's stock has declined by 3.24%, contributing to a loss of 4.05% in the Medical sector, while the S&P 500 gained 3.15% [1] Group 2 - The upcoming earnings report for Tenet Healthcare is scheduled for October 29, 2024, with an expected EPS of $2.33, representing a significant increase of 61.81% year-over-year [2] - Revenue is anticipated to be $5.05 billion, indicating a slight decrease of 0.41% compared to the same quarter last year [2] Group 3 - For the full year, Zacks Consensus Estimates project earnings of $10.72 per share and revenue of $20.84 billion, reflecting increases of 53.58% and 1.4% respectively compared to the previous year [3] Group 4 - Recent adjustments to analyst estimates for Tenet Healthcare suggest positive sentiment regarding the company's business operations and profit generation capabilities [4] - The Zacks Rank system, which evaluates these estimate changes, currently ranks Tenet Healthcare as 1 (Strong Buy), indicating strong potential for stock performance [6] Group 5 - Tenet Healthcare's Forward P/E ratio is 14.62, which is lower than the industry average of 15.39, suggesting that the stock may be undervalued [7] - The company's PEG ratio stands at 0.8, compared to the industry average of 1.13, indicating favorable growth expectations relative to its valuation [8] Group 6 - The Medical - Hospital industry, which includes Tenet Healthcare, holds a Zacks Industry Rank of 2, placing it in the top 1% of over 250 industries, suggesting strong overall performance potential [8][9]

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price. Do they really matter, though? Before we discuss the reliability of brokerage recommendations and how to use them to your advantage, let's see what these Wall Street heavyweights think about Tenet Healthcare (THC) . Tenet currently has an average brokerag ...

Momentum investing is essentially an exception to the idea of "buying low and selling high." Investors following this style of investing are usually not interested in betting on cheap stocks and waiting long for them to recover. Instead, they believe that "buying high and selling higher" is the way to make far more money in lesser time. Everyone likes betting on fast-moving trending stocks, but it isn't easy to determine the right entry point. These stocks often lose momentum when their future growth potent ...

Tenet Healthcare (THC) closed at $166.20 in the latest trading session, marking a +1.83% move from the prior day. The stock outpaced the S&P 500's daily gain of 0.42%. Meanwhile, the Dow gained 0.04%, and the Nasdaq, a tech-heavy index, added 0.38%. Prior to today's trading, shares of the hospital operator had lost 1.58% over the past month. This has was narrower than the Medical sector's loss of 2.49% and lagged the S&P 500's gain of 2.06% in that time. The investment community will be closely monitoring t ...

For-profit hospital operator Tenet Healthcare Corporation (THC) has seen impressive gains in 2024, with shares skyrocketing 118.2%, far outpacing the industry's 50.5% growth and the S&P 500's 19.9% rise. It also outpaced its peers like Universal Health Services, Inc. (UHS) and HCA Healthcare, Inc. (HCA) . This rally has boosted Tenet Healthcare's market capitalization by $8.13 billion in 2024 alone. With this sharp rally, the question for investors is whether to ride the momentum for more potential upside o ...

The investment landscape has shifted in 2024. Sectors outside of technology have used the year to play catchup, and as part of a diversified portfolio, it makes sense to gain exposure to these other areas with significant profit potential. Luckily for investors, the systems used at Zacks Investment Research consistently identify big winners, regardless of which pocket of the market they may reside. Adding to the bullish theme, it's never been easier to find these winners, with the power of the Zacks Rank li ...